Global Amyotrophic Lateral Sclerosis Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Amyotrophic Lateral Sclerosis Therapeutics market size was valued at US$ 293.5 million in 2023. With growing demand in downstream market, the Amyotrophic Lateral Sclerosis Therapeutics is forecast to a readjusted size of US$ 373.6 million by 2030 with a CAGR of 3.5% during review period.
The research report highlights the growth potential of the global Amyotrophic Lateral Sclerosis Therapeutics market. Amyotrophic Lateral Sclerosis Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Amyotrophic Lateral Sclerosis Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Amyotrophic Lateral Sclerosis Therapeutics market.
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
The amyotrophic lateral sclerosis (ALS) therapeutics market is driven by the increasing prevalence of ALS and the growing demand for effective treatments to slow disease progression and improve patient outcomes. As the understanding of ALS pathophysiology improves, researchers and pharmaceutical companies are actively exploring novel therapeutic approaches, including gene therapies and immune-modulating agents. The approval of new ALS drugs and the development of combination therapies further propel market growth. However, challenges include the complexity of ALS as a multi-factorial disease, the difficulty in diagnosing ALS at an early stage, and the high cost of drug development and clinical trials. Addressing these challenges through collaborative research, improved diagnostic tools, and accessible treatment options will be crucial for the sustained growth of the ALS therapeutics market.
Key Features:
The report on Amyotrophic Lateral Sclerosis Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Amyotrophic Lateral Sclerosis Therapeutics market. It may include historical data, market segmentation by Type (e.g., Riluzole, Edaravone (Radicava)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Amyotrophic Lateral Sclerosis Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Amyotrophic Lateral Sclerosis Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Amyotrophic Lateral Sclerosis Therapeutics industry. This include advancements in Amyotrophic Lateral Sclerosis Therapeutics technology, Amyotrophic Lateral Sclerosis Therapeutics new entrants, Amyotrophic Lateral Sclerosis Therapeutics new investment, and other innovations that are shaping the future of Amyotrophic Lateral Sclerosis Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Amyotrophic Lateral Sclerosis Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Amyotrophic Lateral Sclerosis Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Amyotrophic Lateral Sclerosis Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Amyotrophic Lateral Sclerosis Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Amyotrophic Lateral Sclerosis Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Amyotrophic Lateral Sclerosis Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Amyotrophic Lateral Sclerosis Therapeutics market.
Market Segmentation:
Amyotrophic Lateral Sclerosis Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Amyotrophic Lateral Sclerosis Therapeutics market size was valued at US$ 293.5 million in 2023. With growing demand in downstream market, the Amyotrophic Lateral Sclerosis Therapeutics is forecast to a readjusted size of US$ 373.6 million by 2030 with a CAGR of 3.5% during review period.
The research report highlights the growth potential of the global Amyotrophic Lateral Sclerosis Therapeutics market. Amyotrophic Lateral Sclerosis Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Amyotrophic Lateral Sclerosis Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Amyotrophic Lateral Sclerosis Therapeutics market.
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
The amyotrophic lateral sclerosis (ALS) therapeutics market is driven by the increasing prevalence of ALS and the growing demand for effective treatments to slow disease progression and improve patient outcomes. As the understanding of ALS pathophysiology improves, researchers and pharmaceutical companies are actively exploring novel therapeutic approaches, including gene therapies and immune-modulating agents. The approval of new ALS drugs and the development of combination therapies further propel market growth. However, challenges include the complexity of ALS as a multi-factorial disease, the difficulty in diagnosing ALS at an early stage, and the high cost of drug development and clinical trials. Addressing these challenges through collaborative research, improved diagnostic tools, and accessible treatment options will be crucial for the sustained growth of the ALS therapeutics market.
Key Features:
The report on Amyotrophic Lateral Sclerosis Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Amyotrophic Lateral Sclerosis Therapeutics market. It may include historical data, market segmentation by Type (e.g., Riluzole, Edaravone (Radicava)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Amyotrophic Lateral Sclerosis Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Amyotrophic Lateral Sclerosis Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Amyotrophic Lateral Sclerosis Therapeutics industry. This include advancements in Amyotrophic Lateral Sclerosis Therapeutics technology, Amyotrophic Lateral Sclerosis Therapeutics new entrants, Amyotrophic Lateral Sclerosis Therapeutics new investment, and other innovations that are shaping the future of Amyotrophic Lateral Sclerosis Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Amyotrophic Lateral Sclerosis Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Amyotrophic Lateral Sclerosis Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Amyotrophic Lateral Sclerosis Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Amyotrophic Lateral Sclerosis Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Amyotrophic Lateral Sclerosis Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Amyotrophic Lateral Sclerosis Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Amyotrophic Lateral Sclerosis Therapeutics market.
Market Segmentation:
Amyotrophic Lateral Sclerosis Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Riluzole
- Edaravone (Radicava)
- Other
- Hospital
- Drugs Store
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mitsubishi Tanabe Pharma
- Sanofi
- Mylan Pharma
- Apotex
- Glemark Generics
- Covis Pharma
- Sun Pharma
- Lunan Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2030
2.1.2 Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Amyotrophic Lateral Sclerosis Therapeutics Segment by Type
2.2.1 Riluzole
2.2.2 Edaravone (Radicava)
2.2.3 Other
2.3 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
2.3.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Amyotrophic Lateral Sclerosis Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
2.5.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
3 AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Players
3.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS BY REGIONS
4.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth (2019-2024)
4.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth (2019-2024)
4.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024)
5.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)
5.3 Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024)
6.2 APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)
6.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Therapeutics by Country (2019-2024)
7.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)
7.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS MARKET FORECAST
10.1 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Forecast
10.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.2.2 Canada Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.2.3 Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.2.4 Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Forecast by Region (2025-2030)
10.3.1 China Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.2 Japan Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.3 Korea Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.4 Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.5 India Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.6 Australia Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4.2 France Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4.3 UK Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4.4 Italy Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4.5 Russia Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5.2 South Africa Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5.3 Israel Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5.4 Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5.5 GCC Countries Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.6 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Type (2025-2030)
10.7 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Company Information
11.1.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Mitsubishi Tanabe Pharma Main Business Overview
11.1.5 Mitsubishi Tanabe Pharma Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Mylan Pharma
11.3.1 Mylan Pharma Company Information
11.3.2 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mylan Pharma Main Business Overview
11.3.5 Mylan Pharma Latest Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Apotex Main Business Overview
11.4.5 Apotex Latest Developments
11.5 Glemark Generics
11.5.1 Glemark Generics Company Information
11.5.2 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Glemark Generics Main Business Overview
11.5.5 Glemark Generics Latest Developments
11.6 Covis Pharma
11.6.1 Covis Pharma Company Information
11.6.2 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Covis Pharma Main Business Overview
11.6.5 Covis Pharma Latest Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Information
11.7.2 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sun Pharma Main Business Overview
11.7.5 Sun Pharma Latest Developments
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Information
11.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lunan Pharma Main Business Overview
11.8.5 Lunan Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2030
2.1.2 Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Amyotrophic Lateral Sclerosis Therapeutics Segment by Type
2.2.1 Riluzole
2.2.2 Edaravone (Radicava)
2.2.3 Other
2.3 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
2.3.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Amyotrophic Lateral Sclerosis Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
2.5.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
3 AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Players
3.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS BY REGIONS
4.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth (2019-2024)
4.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth (2019-2024)
4.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024)
5.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)
5.3 Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024)
6.2 APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)
6.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Therapeutics by Country (2019-2024)
7.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)
7.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS MARKET FORECAST
10.1 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Forecast
10.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.2.2 Canada Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.2.3 Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.2.4 Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Forecast by Region (2025-2030)
10.3.1 China Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.2 Japan Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.3 Korea Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.4 Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.5 India Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.3.6 Australia Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4.2 France Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4.3 UK Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4.4 Italy Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.4.5 Russia Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5.2 South Africa Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5.3 Israel Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5.4 Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.5.5 GCC Countries Amyotrophic Lateral Sclerosis Therapeutics Market Forecast
10.6 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Type (2025-2030)
10.7 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Company Information
11.1.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Mitsubishi Tanabe Pharma Main Business Overview
11.1.5 Mitsubishi Tanabe Pharma Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Mylan Pharma
11.3.1 Mylan Pharma Company Information
11.3.2 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mylan Pharma Main Business Overview
11.3.5 Mylan Pharma Latest Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Apotex Main Business Overview
11.4.5 Apotex Latest Developments
11.5 Glemark Generics
11.5.1 Glemark Generics Company Information
11.5.2 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Glemark Generics Main Business Overview
11.5.5 Glemark Generics Latest Developments
11.6 Covis Pharma
11.6.1 Covis Pharma Company Information
11.6.2 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Covis Pharma Main Business Overview
11.6.5 Covis Pharma Latest Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Information
11.7.2 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sun Pharma Main Business Overview
11.7.5 Sun Pharma Latest Developments
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Information
11.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lunan Pharma Main Business Overview
11.8.5 Lunan Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Riluzole
Table 3. Major Players of Edaravone (Radicava)
Table 4. Major Players of Other
Table 5. Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Amyotrophic Lateral Sclerosis Therapeutics Key Players Head office and Products Offered
Table 14. Amyotrophic Lateral Sclerosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis Therapeutics
Table 46. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis Therapeutics
Table 47. Key Industry Trends of Amyotrophic Lateral Sclerosis Therapeutics
Table 48. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Mitsubishi Tanabe Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 53. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 54. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Mitsubishi Tanabe Pharma Main Business
Table 56. Mitsubishi Tanabe Pharma Latest Developments
Table 57. Sanofi Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 58. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 59. Sanofi Main Business
Table 60. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Sanofi Latest Developments
Table 62. Mylan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 63. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 64. Mylan Pharma Main Business
Table 65. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Mylan Pharma Latest Developments
Table 67. Apotex Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 68. Apotex Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 69. Apotex Main Business
Table 70. Apotex Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Apotex Latest Developments
Table 72. Glemark Generics Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 73. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 74. Glemark Generics Main Business
Table 75. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Glemark Generics Latest Developments
Table 77. Covis Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 78. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 79. Covis Pharma Main Business
Table 80. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Covis Pharma Latest Developments
Table 82. Sun Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 83. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 84. Sun Pharma Main Business
Table 85. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Sun Pharma Latest Developments
Table 87. Lunan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 88. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 89. Lunan Pharma Main Business
Table 90. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Lunan Pharma Latest Developments
Table 1. Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Riluzole
Table 3. Major Players of Edaravone (Radicava)
Table 4. Major Players of Other
Table 5. Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Amyotrophic Lateral Sclerosis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Amyotrophic Lateral Sclerosis Therapeutics Key Players Head office and Products Offered
Table 14. Amyotrophic Lateral Sclerosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis Therapeutics
Table 46. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis Therapeutics
Table 47. Key Industry Trends of Amyotrophic Lateral Sclerosis Therapeutics
Table 48. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Mitsubishi Tanabe Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 53. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 54. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Mitsubishi Tanabe Pharma Main Business
Table 56. Mitsubishi Tanabe Pharma Latest Developments
Table 57. Sanofi Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 58. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 59. Sanofi Main Business
Table 60. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Sanofi Latest Developments
Table 62. Mylan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 63. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 64. Mylan Pharma Main Business
Table 65. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Mylan Pharma Latest Developments
Table 67. Apotex Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 68. Apotex Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 69. Apotex Main Business
Table 70. Apotex Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Apotex Latest Developments
Table 72. Glemark Generics Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 73. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 74. Glemark Generics Main Business
Table 75. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Glemark Generics Latest Developments
Table 77. Covis Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 78. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 79. Covis Pharma Main Business
Table 80. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Covis Pharma Latest Developments
Table 82. Sun Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 83. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 84. Sun Pharma Main Business
Table 85. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Sun Pharma Latest Developments
Table 87. Lunan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Therapeutics Area Served and Its Competitors
Table 88. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product Offered
Table 89. Lunan Pharma Main Business
Table 90. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Lunan Pharma Latest Developments
LIST OF FIGURES
Figure 1. Amyotrophic Lateral Sclerosis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Amyotrophic Lateral Sclerosis Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Amyotrophic Lateral Sclerosis Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Amyotrophic Lateral Sclerosis Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type in 2023
Figure 10. Amyotrophic Lateral Sclerosis Therapeutics in Hospital
Figure 11. Global Amyotrophic Lateral Sclerosis Therapeutics Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Amyotrophic Lateral Sclerosis Therapeutics in Drugs Store
Figure 13. Global Amyotrophic Lateral Sclerosis Therapeutics Market: Drugs Store (2019-2024) & ($ Millions)
Figure 14. Amyotrophic Lateral Sclerosis Therapeutics in Other
Figure 15. Global Amyotrophic Lateral Sclerosis Therapeutics Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Country in 2023
Figure 24. United States Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Amyotrophic Lateral Sclerosis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Amyotrophic Lateral Sclerosis Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Amyotrophic Lateral Sclerosis Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Amyotrophic Lateral Sclerosis Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type in 2023
Figure 10. Amyotrophic Lateral Sclerosis Therapeutics in Hospital
Figure 11. Global Amyotrophic Lateral Sclerosis Therapeutics Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Amyotrophic Lateral Sclerosis Therapeutics in Drugs Store
Figure 13. Global Amyotrophic Lateral Sclerosis Therapeutics Market: Drugs Store (2019-2024) & ($ Millions)
Figure 14. Amyotrophic Lateral Sclerosis Therapeutics in Other
Figure 15. Global Amyotrophic Lateral Sclerosis Therapeutics Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Country in 2023
Figure 24. United States Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Amyotrophic Lateral Sclerosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share Forecast by Application (2025-2030)
